Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nerve Growth Factor eye drops as visual rescue treatment in optic gliomas
2011-003030-14Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Nerve growth factor in optic nerve glioma (OPG), sponsored by Policlinico Gemelli. Primary endpoint: Improvement of visual function. Started Sep 2012; status: completed.
02
Drugs
Nerve growth factor
03
Conditions
optic nerve glioma (OPG)
Beyond the preview
Go deeper on 2011-003030-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003030-14.